Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 131 articles:
HTML format
Text format



Single Articles


    April 2017
  1. GUERRIOS-RIVERA L, Howard L, Frank J, De Hoedt A, et al
    Is BMI the Best Adiposity Measure for Prostate Cancer Risk? Results From a VA Biopsy Cohort.
    Urology. 2017 Apr 10. pii: S0090-4295(17)30347.
    PubMed     Text format     Abstract available


    March 2017
  2. JOHNSTON J, Struss WJ, Black PC
    Padeliporfin Vascular-Targeted Photodynamic Therapy Versus Active Surveillance in Men with Low-Risk Prostate Cancer (Clin1001 PCM301): an Open-Label, Phase 3, Randomised Control Trial.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30274.
    PubMed     Text format    


  3. STRUSS WJ, Black PC
    Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30275.
    PubMed     Text format    


  4. PAKZAD R, Safiri S
    Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study; Methodological Issues.
    Urology. 2017 Mar 21. pii: S0090-4295(17)30272.
    PubMed     Text format    


  5. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Reply to Letter-to-the-Editor: Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study, Published in Urology. 2017 Jan;99:148-154.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30269.
    PubMed     Text format    


  6. JOSHI A, Nicholson C, Rhee H, Gustafson S, et al
    Incidental Malignancies identified during staging for Prostate Cancer with 68Ga -PSMA HBED-CC PET imaging.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30271.
    PubMed     Text format     Abstract available


  7. LU AJ, Syed JS, Nguyen KA, Nawaf CB, et al
    Negative Multi-Parametric MRI of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
    Urology. 2017 Mar 16. pii: S0090-4295(17)30247.
    PubMed     Text format     Abstract available


  8. PAKZAD R, Safiri S
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer: Methodological Issues.
    Urology. 2017 Mar 15. pii: S0090-4295(17)30244.
    PubMed     Text format    



  9. Erratum to "Predictors of Time to Metastasis in Castration-resistant Prostate Cancer".
    Urology. 2017 Mar 14. pii: S0090-4295(17)30113.
    PubMed     Text format    


  10. CRAWFORD ED, Petrylak DP, Shore N, Saad F, et al
    The Role of Therapeutic Layering in Optimizing Treatment for Patients with Castration-Resistant Prostate Cancer (RADAR II).
    Urology. 2017 Mar 13. pii: S0090-4295(16)31023.
    PubMed     Text format     Abstract available


    February 2017
  11. GORDETSKY J, Rais-Bahrami S, Epstein JI
    Pathological Findings in Multiparametric MRI/Ultrasound Fusion Guided Biopsy: Relation to Prostate Cancer Focal Therapy.
    Urology. 2017 Feb 23. pii: S0090-4295(17)30163.
    PubMed     Text format     Abstract available


  12. AUFFENBERG GB, Merdan S, Miller DC, Singh K, et al
    Evaluation of Prostate Cancer Risk Calculators for Shared-Decision Making Across Diverse Urology Practices in Michigan.
    Urology. 2017 Feb 22. pii: S0090-4295(17)30165.
    PubMed     Text format     Abstract available


  13. LANG MF, Tyson MD, Rudd Alvarez J, Koyama T, et al
    The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-Based Cohort.
    Urology. 2017 Feb 9. pii: S0090-4295(17)30123.
    PubMed     Text format     Abstract available


  14. GUNLUSOY B, Ceylan Y, Koskderlioglu A, Gedizlioglu M, et al
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer.
    Urology. 2017 Feb 7. pii: S0090-4295(17)30116.
    PubMed     Text format     Abstract available


  15. KIRK PS, Govani S, Borza T, Hollenbeck BK, et al
    Implications of Prostate Cancer Treatment in Men with Inflammatory Bowel Disease.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30111.
    PubMed     Text format     Abstract available


    January 2017
  16. LIU JZ, Yin FY, Yan CY, Wang H, et al
    Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by Hsa-miR-125A-3P via Modulation of MTA1 Signaling.
    Urology. 2017 Jan 11. pii: S0090-4295(17)30013.
    PubMed     Text format     Abstract available


  17. FROEHNER M, Kuithan F, Zophel K, Heberling U, et al
    Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate Cancer.
    Urology. 2017 Jan 4. pii: S0090-4295(16)30923.
    PubMed     Text format     Abstract available


    December 2016
  18. FREITAS D, Andriole GL, Castro-Santamaria R, Freedland SJ, et al
    Extent of Baseline Prostate Atrophy is Associated with Lower Incidence of Low- and High-Grade Prostate Cancer on Repeat Biopsy.
    Urology. 2016 Dec 23. pii: S0090-4295(16)31014.
    PubMed     Text format     Abstract available


  19. KIM EH, Weaver JK, Shetty AS, Vetter JM, et al
    Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients with Estimated Risk of High Grade Prostate Cancer Less Than or Equal to 10.
    Urology. 2016 Dec 2. pii: S0090-4295(16)30917.
    PubMed     Text format     Abstract available


    November 2016
  20. ODERDA M, Cozzi G, Daniele L, Sapino A, et al
    CCP-Score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients.
    Urology. 2016 Nov 25. pii: S0090-4295(16)30914.
    PubMed     Text format     Abstract available


  21. O'SHAUGHNESSY MJ, McBride SM, Vargas HA, Touijer KA, et al
    A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early Stage Metastatic Prostate Cancer.
    Urology. 2016 Nov 22. pii: S0090-4295(16)30850.
    PubMed     Text format     Abstract available


  22. TURNER RM 2ND, Yecies TS, Yabes JG, Ristau BT, et al
    Biopsy Perineural Invasion in Prostate Cancer Patients Who are Candidates for Active Surveillance by Strict and Expanded Criteria.
    Urology. 2016 Nov 15. pii: S0090-4295(16)30826.
    PubMed     Text format     Abstract available


  23. GOMEZ-GOMEZ E, Carrasco-Valiente J, Blanca-Pedregosa A, Barco-Sanchez B, et al
    European Randomised Study for Screening of Prostate Cancer Risk Calculator: External Validation, Variability and Clinical Significance.
    Urology. 2016 Nov 10. pii: S0090-4295(16)30808.
    PubMed     Text format     Abstract available


    October 2016
  24. CUTRUZZULA P, Edwards D, Cahn D, Tong C, et al
    Metastatic Prostate Cancer Presenting as Lower Extremity Soft Tissue Mass: a Rare Case Presentation.
    Urology. 2016 Oct 17. pii: S0090-4295(16)30710.
    PubMed     Text format     Abstract available


  25. LEAPMAN M, Jazayeri SB, Katsigeorgis M, Hobbs A, et al
    Patient-Perceived Causes of Prostate Cancer: Result of an Internet Based Survey.
    Urology. 2016 Oct 17. pii: S0090-4295(16)30707.
    PubMed     Text format     Abstract available


  26. BOISSIER R, Udrescu C, Rebillard X, Terrier JE, et al
    Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Urology. 2016 Oct 7. pii: S0090-4295(16)30699.
    PubMed     Text format     Abstract available


  27. JONES TA, Natarajan S, Priester AM, Marks LS, et al
    Images in Clinical Urology - Focal Laser Ablation of Prostate Cancer.
    Urology. 2016 Oct 6. pii: S0090-4295(16)30700.
    PubMed     Text format     Abstract available


    September 2016
  28. MOSES KA, Orom H, Brasel A, Gaddy J, et al
    Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter.
    Urology. 2016 Sep 22. pii: S0090-4295(16)30579.
    PubMed     Text format     Abstract available


  29. RUDICHUK L, Vogel KJ, Wang CH, Helfand BT, et al
    Urologists' Current Practices in Screening and Treating Men with a Family History of Prostate Cancer.
    Urology. 2016 Sep 16. pii: S0090-4295(16)30460.
    PubMed     Text format     Abstract available


  30. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Urology. 2016 Sep 16. pii: S0090-4295(16)30625.
    PubMed     Text format     Abstract available


  31. SISSUNG TM, Venzon DJ, Figg WD
    Erratum to: Association of a CYP17 Polymorphism With Overall Survival in Caucasian Patients With Androgen-independent Prostate Cancer.
    Urology. 2016;95:225.
    PubMed     Text format    


  32. EGEVAD L, Samaratunga H, Srigley JR, Delahunt B, et al
    Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.
    Urology. 2016 Sep 1. pii: S0090-4295(16)30402.
    PubMed     Text format    


  33. TAN WP, Lin C, Chen M, Deane L, et al
    Periprostatic Fat: A Risk Factor for Prostate Cancer?
    Urology. 2016 Sep 1. pii: S0090-4295(16)30551.
    PubMed     Text format     Abstract available


    August 2016
  34. GHABILI K, Tosoian JJ, Schaeffer EM, Pavlovich CP, et al
    The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies.
    Urology. 2016 Aug 31. pii: S0090-4295(16)30547.
    PubMed     Text format    


  35. LAVIEN G, Chery G, Zaid UB, Peterson AC, et al
    Pubic Bone Resection Provides Objective Pain Control in the Prostate Cancer Survivor with Pubic Bone Osteomyelitis with an Associated Urinary Tract to Pubic Symphysis Fistula.
    Urology. 2016 Aug 31. pii: S0090-4295(16)30550.
    PubMed     Text format     Abstract available


  36. FENSTERMAKER M, Mendhiratta N, Bjurlin MA, Meng X, et al
    Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.
    Urology. 2016 Aug 22. pii: S0090-4295(16)30535.
    PubMed     Text format     Abstract available


  37. KIM SP, Karnes RJ, Gross CP, Meropol NJ, et al
    Contemporary National Trends of Prostate Cancer Screening among Privately Insured Men in the United States.
    Urology. 2016 Aug 12. pii: S0090-4295(16)30512.
    PubMed     Text format     Abstract available


  38. WALLIS CJ, Mahar AL, Satkunasivam R, Herschorn S, et al
    Cardiovascular and Skeletal-Related Events Following Localised Prostate Cancer Treatment: Role of Surgery, Radiotherapy and Androgen-Deprivation.
    Urology. 2016 Aug 5. pii: S0090-4295(16)30494.
    PubMed     Text format     Abstract available


    July 2016
  39. CRAWFORD ED, Rosenberg MT, Partin AW, Cooperberg MR, et al
    An Approach Using PSA Levels of 1.5 ng/ml as the Cutoff for Prostate Cancer Screening in Primary Care.
    Urology. 2016 Jul 19. pii: S0090-4295(16)30383.
    PubMed     Text format    


  40. KLEIN EA, Smith JA, Zietman AL, Dasgupta P, et al
    Reply to the Letter to the Editor #16-01352: "Consensus Guidelines for Reporting Prostate Cancer Gleason Grade" by Hemamali Samaratunga.
    Urology. 2016 Jul 18. pii: S0090-4295(16)30401.
    PubMed     Text format    


  41. MORGIA G, Russo GI, Tubaro A, Bortolus R, et al
    Prevalence of Cardiovascular Disease and Osteoporosis during Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multi-Center Cross-Sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study.
    Urology. 2016 Jul 8. pii: S0090-4295(16)30315.
    PubMed     Text format     Abstract available


  42. ADEJORO O, Alishahi A, Konety B
    Association of Comorbidity, Age and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Urology. 2016 Jul 7. pii: S0090-4295(16)30303.
    PubMed     Text format     Abstract available


  43. LESTER-COLL NH, Park HS, Rutter CE, Corso CD, et al
    The Association between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-Risk Prostate Cancer.
    Urology. 2016 Jul 5. pii: S0090-4295(16)30371.
    PubMed     Text format     Abstract available


    June 2016
  44. ZHANG JH, Reichard CA, Plesec TP, Klein EA, et al
    A Case of Prostate Cancer in Lynch Syndrome.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30289.
    PubMed     Text format    


  45. MOREIRA DM, Howard LE, Sourbeer KN, Amarasekara HS, et al
    Predictors of Time to Metastasis in Castration-Resistant Prostate Cancer.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30294.
    PubMed     Text format     Abstract available


  46. WANG EH, Yu JB, Abouassally R, Meropol NJ, et al
    Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results From A Population-Based Cohort.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30293.
    PubMed     Text format     Abstract available


  47. WU FJ, Sheu SY, Lin HC, Chung SD, et al
    Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30299.
    PubMed     Text format     Abstract available


  48. WALLIS CJ, Mahar AL, Cheung P, Herschorn S, et al
    Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older Men.
    Urology. 2016 Jun 8. pii: S0090-4295(16)30265.
    PubMed     Text format     Abstract available


  49. SHAH N, Ioffe V
    Re: The Memorial Sloan Kettering cancer center recommendations for prostate cancer screening. Andrew J Vickers et al. Urology 91: 12-18, 2016.
    Urology. 2016 Jun 1. pii: S0090-4295(16)30260.
    PubMed     Text format    


  50. VICKERS AJ, Eastham JA, Scardino PT, Lilja H, et al
    Reply to RE: The Memorial Sloan Kettering Cancer Center recommendations for prostate cancer screening.
    Urology. 2016 Jun 1. pii: S0090-4295(16)30257.
    PubMed     Text format    


    May 2016
  51. COHEN A, Lapin B, Wang CH, Helfand B, et al
    Variation in Testosterone Levels and Health Related Quality of Life in Men Diagnosed with Prostate Cancer on Active Surveillance.
    Urology. 2016 May 11. pii: S0090-4295(16)30152.
    PubMed     Text format     Abstract available


  52. SUN Y, Jia X, Hou L, Liu X, et al
    Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
    Urology. 2016 May 11. pii: S0090-4295(16)30149.
    PubMed     Text format     Abstract available


  53. HANSEN NL, Caglic I, Berman LH, Kastner C, et al
    Multiparametric Prostate MRI and Cognitively Targeted Transperineal Biopsy in Patients with Previous Abdominoperineal Resection and Suspicion of Prostate Cancer.
    Urology. 2016 May 4. pii: S0090-4295(16)30141.
    PubMed     Text format     Abstract available


    April 2016
  54. IREMASHVILI V, Kava BR, Manoharan M, Parekh DJ, et al
    Is It Time to Revisit the Role of Prostate-Specific Antigen Kinetics in Active Surveillance for Prostate Cancer?
    Urology. 2016 Apr 26. pii: S0090-4295(16)30111.
    PubMed     Text format     Abstract available


  55. SERTKAYA Z
    Re: Fascelli M, Et Al. Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy-Naive Patient Population.
    Urology. 2016 Apr 22. pii: S0090-4295(16)30106.
    PubMed     Text format    


  56. VAN ASSELDONK B, Black P, Elterman DS
    Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects.
    Urology. 2016 Apr 20. pii: S0090-4295(16)30059.
    PubMed     Text format    


  57. DASKIVICH TJ, Lai J, Dick AW, Setodji CM, et al
    Questioning the Ten-Year Life Expectancy Rule for High-Grade Prostate Cancer: Comparative Effectiveness of Aggressive Vs. Non-Aggressive Treatment of High-Grade Disease in Older Men with Differing Comorbid Disease Burdens.
    Urology. 2016 Apr 11. pii: S0090-4295(16)30064.
    PubMed     Text format     Abstract available


  58. KLEIN EA, Haddad Z, Yousefi K, Lam LL, et al
    Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
    Urology. 2016;90:148-52.
    PubMed     Text format     Abstract available


  59. SCHWEN ZR, Tosoian JJ, Sokoll LJ, Mangold L, et al
    Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.
    Urology. 2016;90:136-40.
    PubMed     Text format     Abstract available


  60. BENSON MC
    Editorial Comment.
    Urology. 2016;90:147.
    PubMed     Text format    


  61. KROUWEL EM, Elzevier HW
    Author Reply.
    Urology. 2016;90:25-6.
    PubMed     Text format    


  62. NIEDER AM
    Editorial Comment.
    Urology. 2016;90:25.
    PubMed     Text format    


    March 2016
  63. BHINDI B, Xie WY, Kulkarni GS, Hamilton RJ, et al
    Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.
    Urology. 2016 Mar 22. pii: S0090-4295(16)00302.
    PubMed     Text format     Abstract available


  64. ZIETMAN A, Smith J, Klein E, Droller M, et al
    Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.
    Urology. 2016 Mar 22. pii: S0090-4295(16)00280.
    PubMed     Text format    


  65. OSTBY-DEGLUM M, Axcrona K, Brennhovd B, Dahl AA, et al
    Ability to Reach Orgasm in Patients with Prostate Cancer Treated with Robot-assisted Laparoscopic Prostatectomy.
    Urology. 2016 Mar 10. pii: S0090-4295(16)00285.
    PubMed     Text format     Abstract available


  66. MANDEL P, Kriegmair MC, Veleva V, Salomon G, et al
    The Role of Pelvic Lymph Node Dissection during Radical Prostatectomy in Patients with Gleason Grade 6 Intermediate-Risk Prostate Cancer.
    Urology. 2016 Mar 8. pii: S0090-4295(16)00276.
    PubMed     Text format     Abstract available


  67. KISS B, Thoeny HC, Studer UE
    Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
    Urology. 2016 Mar 7. pii: S0090-4295(16)00182.
    PubMed     Text format     Abstract available


    February 2016
  68. SHORE ND, Crawford ED, Higano CS, Sartor O, et al
    Advancing Treatment Strategies in Metastatic Castration-resistant Prostate Cancer: The Urologists Role.
    Urology. 2016 Feb 25. pii: S0090-4295(15)01158.
    PubMed     Text format    


  69. DE SANTIS M, Saad F
    Practical Guidance on the Role of Corticosteroids in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2016 Feb 18. pii: S0090-4295(16)00146.
    PubMed     Text format     Abstract available


  70. PETRELLI F, Vavassori I, Cabiddu M, Coinu A, et al
    Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: a Systematic Review and Meta-Analysis.
    Urology. 2016 Feb 16. pii: S0090-4295(16)00127.
    PubMed     Text format     Abstract available


  71. KLAFF R, Rosell J, Varenhorst E, Sandblom G, et al
    The Long-Term Disease-Specific Mortality of Low-Risk Localized Prostate Cancer: a Prospective Population-Based Register Study Over Two Decades.
    Urology. 2016 Feb 12. pii: S0090-4295(16)00126.
    PubMed     Text format     Abstract available


  72. GAYLIS F, Cohen E, Calabrese R, Prime H, et al
    Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage and Improve?
    Urology. 2016 Feb 11. pii: S0090-4295(16)00112.
    PubMed     Text format     Abstract available


  73. VICKERS AJ, Eastham JA, Scardino PT, Lilja H, et al
    The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.
    Urology. 2016 Feb 2. pii: S0090-4295(16)00070.
    PubMed     Text format     Abstract available


  74. GEORGE AK, Rais-Bahrami S, Fascelli M, Turkbeyc B, et al
    Author Reply.
    Urology. 2016;88:133-4.
    PubMed     Text format    


  75. HOIMES CJ, Madabhushi A
    Editorial Comment.
    Urology. 2016;88:132-3.
    PubMed     Text format    


  76. BAKER D
    Editorial Comment.
    Urology. 2016;88:41-2.
    PubMed     Text format    


  77. SHIKANOV S
    Editorial Comment.
    Urology. 2016;88:41.
    PubMed     Text format    


  78. PAICH K, Wittmann D
    Author Reply.
    Urology. 2016;88:42.
    PubMed     Text format    


    January 2016
  79. KRYVENKO ON
    Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution: Author's Reply.
    Urology. 2016 Jan 25. pii: S0090-4295(16)00074.
    PubMed     Text format    


  80. PISHGAR F
    Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution.
    Urology. 2016 Jan 22. pii: S0090-4295(16)00073.
    PubMed     Text format    


  81. RAI BP, Baum R, Patel A, Hughes R, et al
    The Role PET with Gallium (Ga)-Labelled Prostate-Specific Membrane Antigen (PSMA) in the Management of Patient with Organ Confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and after Radical Prostatectomy.
    Urology. 2016 Jan 11. pii: S0090-4295(16)00011.
    PubMed     Text format     Abstract available


  82. KRYVENKO ON, Diaz M, Matoso A, Kates M, et al
    PSA Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity: Related PSA Hemodilution.
    Urology. 2016 Jan 7. pii: S0090-4295(16)00002.
    PubMed     Text format     Abstract available


  83. KROUWEL EM, Palacios LA, Putter H, Pelger RC, et al
    Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need.
    Urology. 2016 Jan 6. pii: S0090-4295(15)01194.
    PubMed     Text format     Abstract available


  84. HENSEL J, Thalmann GN
    Biology of Bone Metastases in Prostate Cancer.
    Urology. 2016 Jan 5. pii: S0090-4295(15)01193.
    PubMed     Text format     Abstract available


  85. NGUYEN PL
    Editorial comment.
    Urology. 2016;87:152.
    PubMed     Text format    


  86. MOUL JW
    Editorial comment.
    Urology. 2016;87:131-2.
    PubMed     Text format    


  87. REEVES F, Everaerts W, Murphy DG, Kiers L, et al
    Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy.
    Urology. 2016;87:133-9.
    PubMed     Text format     Abstract available


    December 2015
  88. CHEDGY EC, Black PC
    "Moving Beyond the Androgen Receptor in Advanced Prostate Cancer".
    Urology. 2015 Dec 23. pii: S0090-4295(15)01107.
    PubMed     Text format    


  89. BRAND TC, Zhang N, Crager MR, Maddala T, et al
    Patient-Specific Meta-Analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
    Urology. 2015 Dec 23. pii: S0090-4295(15)01142.
    PubMed     Text format     Abstract available


  90. FASCELLI M, Rais-Bahrami S, Sankineni S, Brown AM, et al
    Combined Biparametric Prostate MRI and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy Naive Patient Population.
    Urology. 2015 Dec 8. pii: S0090-4295(15)01091.
    PubMed     Text format     Abstract available


    November 2015
  91. JAROW JP, Ahmed HU, Choyke PL, Taneja SS, et al
    Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop.
    Urology. 2015 Nov 24. pii: S0090-4295(15)01066.
    PubMed     Text format     Abstract available


  92. BIDNUR S, Black PC
    Comparison of MR/Ultrasound Fusion-Guided Biopsy with Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer.
    Urology. 2015 Nov 5. pii: S0090-4295(15)00959.
    PubMed     Text format     Abstract available


  93. WEAVER JK, Kim EH, Vetter JM, Fowler KJ, et al
    Presence of MRI Suspicious Lesion Predicts Gleason 7 or Greater Prostate Cancer in Biopsy Naive Patients.
    Urology. 2015 Nov 3. pii: S0090-4295(15)01012.
    PubMed     Text format     Abstract available


  94. PAICH K, Dunn RL, Skolarus T, Montie J, et al
    Preparing Patients and Partners for the Recovery From the Side-Effects of Prostate Cancer Surgery: a Group Approach.
    Urology. 2015 Nov 2. pii: S0090-4295(15)00935.
    PubMed     Text format     Abstract available


    October 2015
  95. TRIPATHI S, Trabulsi EJ, Gomella L, Kim S, et al
    VPAC1 Targeted Cu-TP3805 PET Imaging of Prostate Cancer: Preliminary Evaluation in Man.
    Urology. 2015 Oct 28. pii: S0090-4295(15)00991.
    PubMed     Text format     Abstract available


  96. KOHUTEK ZA, Steinberger E, Pei X, Shi W, et al
    Long-Term Impact of Androgen-Deprivation Therapy on Cardiovascular Morbidity after Radiotherapy for Clinically Localized Prostate Cancer.
    Urology. 2015 Oct 14. pii: S0090-4295(15)00904.
    PubMed     Text format     Abstract available


  97. LEPOR H
    Reply: To PMID 26163812.
    Urology. 2015;86:788-9.
    PubMed     Text format    


  98. MOUL JW
    Editorial Comment.
    Urology. 2015;86:788.
    PubMed     Text format    


  99. JOHNSON D
    Editorial Comment.
    Urology. 2015;86:823.
    PubMed     Text format    


  100. PACKIAM VT, Patel SG, Pariser JJ, Richards KA, et al
    Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.
    Urology. 2015;86:777-82.
    PubMed     Text format     Abstract available


  101. MURPHY G, Haddock P, Doak H, Jackson M, et al
    Urinary Bother as a Predictor of Postsurgical Changes in Urinary Function After Robotic Radical Prostatectomy.
    Urology. 2015;86:817-23.
    PubMed     Text format     Abstract available


    September 2015
  102. DINH KT, Muralidhar V, Mahal BA, Chen YW, et al
    Occult High-Risk Disease in Clinically Low-Risk Prostate Cancer with >/=50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low-Risk?
    Urology. 2015 Sep 18. pii: S0090-4295(15)00895.
    PubMed     Text format     Abstract available


  103. VAISHAMPAYAN U, Shevrin D, Stein M, Heilbrun L, et al
    Phase II trial of carboplatin, everolimus and prednisone in metastatic castrate resistant prostate cancer pretreated with docetaxel chemotherapy: A Prostate Cancer Clinical Trial Consortium Study.
    Urology. 2015 Sep 12. pii: S0090-4295(15)00798.
    PubMed     Text format     Abstract available


  104. TRAN S, Boissier R, Perrin J, Karsenty G, et al
    Review of the different treatments and management for prostate cancer and fertility.
    Urology. 2015 Sep 11. pii: S0090-4295(15)00660.
    PubMed     Text format     Abstract available


  105. LIU J, Womble PR, Merdan S, Miller DC, et al
    Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
    Urology. 2015 Sep 7. pii: S0090-4295(15)00836.
    PubMed     Text format     Abstract available


  106. NASSIRI N, Natarajan S, Margolis DJ, Marks LS, et al
    Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology.
    Urology. 2015;86:432-8.
    PubMed     Text format     Abstract available


  107. MARKOWSKI MC, Eisenberger MA, Zahurak M, Epstein JI, et al
    Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital.
    Urology. 2015;86:539-43.
    PubMed     Text format     Abstract available


  108. LOEB S
    Editorial Comment.
    Urology. 2015;86:504-5.
    PubMed     Text format    


  109. BRAWLEY OW
    Editorial Comment.
    Urology. 2015;86:504.
    PubMed     Text format    


  110. WALLNER LP, Loo RK, Jacobsen SJ
    Reply: To PMID 26123517.
    Urology. 2015;86:505.
    PubMed     Text format    


    August 2015
  111. SAAD F, Fizazi KS
    Androgen Deprivation Therapy and Secondary Hormone Therapy in the Management of Hormone-Sensitive and Castration Resistant Prostate Cancer.
    Urology. 2015 Aug 14. pii: S0090-4295(15)00729.
    PubMed     Text format     Abstract available


  112. EMINAGA O, Hinkelammert R, Abbas M, Wotzel F, et al
    Preoperative Serum Prostate Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.
    Urology. 2015 Aug 5. pii: S0090-4295(15)00713.
    PubMed     Text format     Abstract available


  113. ANASTASIADIS E, Charman SC, Arumainayagam N, Sohaib AS, et al
    What Burden of Prostate Cancer Can Radiologists Rule Out on Multiparametric Magnetic Resonance Imaging? A Sensitivity Analysis Based on Varying the Target Condition in Template Prostate Mapping Biopsies.
    Urology. 2015 Aug 4. pii: S0090-4295(15)00479.
    PubMed     Text format     Abstract available


  114. TRUONG H, Counsilman MJ, Gooptu M, Pulte E, et al
    Orbital Compartment Syndrome as the Presenting Sign of Disseminated Intravascular Coagulation From Metastatic Prostatic Cancer to the Orbit.
    Urology. 2015;86:e7-8.
    PubMed     Text format     Abstract available


    July 2015
  115. MENDHIRATTA N, Lee T, Prabhu V, Llukani E, et al
    10-year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate Specific Antigen Screening Era.
    Urology. 2015 Jul 8. pii: S0090-4295(15)00635.
    PubMed     Text format     Abstract available


  116. MAXEINER A, Stephan C, Durmus T, Slowinski T, et al
    Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer.
    Urology. 2015;86:108-14.
    PubMed     Text format     Abstract available


  117. AYDOGMUS Y, Kilinc MF, Kabar M, Ozer E, et al
    Metastasis of Prostate Adenocarcinoma to the Testis.
    Urology. 2015;86:206.
    PubMed     Text format    


  118. NGUYEN PL, Shin H, Yousefi K, Thompson DJ, et al
    Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
    Urology. 2015;86:35-40.
    PubMed     Text format     Abstract available


    June 2015
  119. WALLNER LP, Hsu JY, Loo RK, Palmer-Toy DE, et al
    Trends in prostate specific antigen screening, prostate biopsies, urology visits and prostate cancer treatments from 2000 to 2012.
    Urology. 2015 Jun 26. pii: S0090-4295(15)00587.
    PubMed     Text format     Abstract available


  120. FENG TS, Sharif-Afshar AR, Wu J, Li Q, et al
    Multiparametric MRI Improves Accuracy of Clinical Nomograms for Predicting Extracapsular Extension of Prostate Cancer.
    Urology. 2015 Jun 14. pii: S0090-4295(15)00554.
    PubMed     Text format     Abstract available


  121. ELKOUSHY MA, Elshal AM, Elhilali MM
    Incidental Prostate Cancer Diagnosis During Holmium Laser Enucleation: Assessment of Predictors, Survival, and Disease Progression.
    Urology. 2015 Jun 11. pii: S0090-4295(15)00553.
    PubMed     Text format     Abstract available


  122. FARIA EF, Chapin BF, Muller RL, Machado RD, et al
    Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status.
    Urology. 2015 Jun 2. pii: S0090-4295(15)00265.
    PubMed     Text format     Abstract available


  123. LEBEIS C, Canes D, Sorcini A, Moinzadeh A, et al
    Novel Technique Prevents Lymphoceles After Transperitoneal Robotic-assisted Pelvic Lymph Node Dissection: Peritoneal Flap Interposition.
    Urology. 2015;85:1505-9.
    PubMed     Text format     Abstract available


  124. DOWRICK AS, Wootten AC, Murphy DG, Costello AJ, et al
    "We Used a Validated Questionnaire": What Does This Mean and Is It an Accurate Statement in Urologic Research?
    Urology. 2015;85:1304-10.
    PubMed     Text format     Abstract available


  125. KADONO Y, Ueno S, Iwamoto D, Takezawa Y, et al
    Chronological Urodynamic Evaluation of Changing Bladder and Urethral Functions After Robot-assisted Radical Prostatectomy.
    Urology. 2015;85:1441-7.
    PubMed     Text format     Abstract available


  126. ABDELSAYED GA, Danial T, Kaswick JA, Finley DS, et al
    Tumors of the Anterior Prostate: Implications for Diagnosis and Treatment.
    Urology. 2015;85:1224-8.
    PubMed     Text format     Abstract available


    May 2015
  127. LEE T, Fenstermaker M, Taksler GB, Lepor H, et al
    Long-term Satisfaction After Open Radical Prostatectomy.
    Urology. 2015;85:1130-6.
    PubMed     Text format     Abstract available


    April 2015
  128. SELKIRK CG, Wang CH, Helfand BT
    Reply: To PMID 25709045.
    Urology. 2015;85:746-7.
    PubMed     Text format    


  129. THOMAS C, Thuroff JW
    Editorial comment.
    Urology. 2015;85:746.
    PubMed     Text format    


  130. WANG EH, Yu JB, Gross CP, Abouassaly R, et al
    Association between surgeon and hospital characteristics and lymph node counts from radical prostatectomy and pelvic lymph node dissection.
    Urology. 2015;85:890-5.
    PubMed     Text format     Abstract available


  131. GEORGIADES F, Ioannides C, Kourieos A, Grange P, et al
    A perivesical mass in a 79-year-old with a treated adenocarcinoma of the prostate.
    Urology. 2015;85:713-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: